VolitionRx Ltd Reports Results for Quarter Ended June 30, 2026

What Happened

• VolitionRx Limited (VNRX) furnished a Form 8‑K on August 13, 2026 announcing its financial results and business updates for the quarter ended June 30, 2026. The company issued a press release (Exhibit 99.1) and confirmed a conference call for August 14, 2026 at 8:30 a.m. U.S. Eastern Time.
• The information in the press release was “furnished” under General Instruction B.2. of Form 8‑K, meaning it is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act and is not automatically incorporated by reference into other filings.

Key Details

• Filing date: August 13, 2026 (Form 8‑K Item 2.02).
• Period covered: quarter ended June 30, 2026.
• Company action: issued press release (Exhibit 99.1) and scheduled investor conference call for August 14, 2026 at 8:30 a.m. ET.
• Legal note: press release furnished (not filed), per Form 8‑K disclosure.

Why It Matters

• Investors should expect updated quarterly earnings and business information from VolitionRx that could affect near‑term trading and investor sentiment. The scheduled conference call on August 14 provides an opportunity for management to discuss results and answer questions.
• Because the release was furnished (not filed), it carries different legal implications—investors should review the press release (Exhibit 99.1) and listen to the call for specific figures and management commentary to assess revenue, profitability, and operational updates.